Although endogenous expression and function of the AhR in breast cancer cells is variable, the effects of structurally diverse AhR ligands (Table 1, Table 2 and Table 3) are primarily associated with selective inhibition of pro-oncogenic responses. Here, AHR is linked to breast cancer.